1.
Buss CG, Dudani JS, Akana RTK, Fleming HE, Bhatia SN. Protease activity sensors noninvasively classify bacterial infections and antibiotic responses. EBioMedicine. 2018;38:248-256. doi:10.1016/j.ebiom.2018.11.031.
1.
Cohen DT, Zhang C, Fadzen CM, et al. A chemoselective strategy for late-stage functionalization of complex small molecules with polypeptides and proteins. Nat Chem. 2019;11(1):78-85. doi:10.1038/s41557-018-0154-0.
1.
Groussin M, Poyet M, Sistiaga A, et al. Elevated rates of horizontal gene transfer in the industrialized human microbiome. Cell. 2021;184(8):2053-2067.e18. doi:10.1016/j.cell.2021.02.052.
1.
Gootenberg JS, Abudayyeh OO, Lee JW, et al. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science. 2017;356(6336):438-442. doi:10.1126/science.aam9321.
1.
Song M, Chan AT, Sun J. Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. Gastroenterology. 2020;158(2):322-340. doi:10.1053/j.gastro.2019.06.048.
1.
Yang JH, Bening SC, Collins JJ. Antibiotic efficacy-context matters. Curr Opin Microbiol. 2017;39:73-80. doi:10.1016/j.mib.2017.09.002.
1.
Makarova KS, Wolf YI, Iranzo J, et al. Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. Nat Rev Microbiol. 2020;18(2):67-83. doi:10.1038/s41579-019-0299-x.
1.
Sinha R, Abu-Ali G, Vogtmann E, et al. Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. Nat Biotechnol. 2017;35(11):1077-1086. doi:10.1038/nbt.3981.
1.
Meylan S, Andrews IW, Collins JJ. Targeting Antibiotic Tolerance, Pathogen by Pathogen. Cell. 2018;172(6):1228-1238. doi:10.1016/j.cell.2018.01.037.
1.
Komor AC, Badran AH, Liu DR. Editing the Genome Without Double-Stranded DNA Breaks. ACS Chem Biol. 2018;13(2):383-388. doi:10.1021/acschembio.7b00710.